Placenta-Derived Cell-Conditioned Medium for Animal-Free Stem Cell Culture
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for culturing human induced pluripotent stem cells using animal-derived support cells and special gels pose safety concerns and are not economically viable for mass production, as they can lead to heterologous protein contamination and high costs.
Innovation Solution
Employing a placenta-derived cell-conditioned medium (PCCM) for inducing dedifferentiation of somatic cells into induced pluripotent stem cells, using placenta-derived fibroblast-like cells isolated from the human chorionic plate, and transducing nucleic acid sequences encoding proteins like OCT4, SOX2, c-Myc, and KLF4, to create an animal-free and feeder-free culture system.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If animal-derived support cells and special gels are used for culturing human induced pluripotent stem cells, then stem cell culture can be performed, but safety problems arise due to heterologous protein contamination
Solution Approach 1:
The patent extracts and eliminates animal-derived components from the culture system by using placenta-derived fibroblast-like cells as feeder cells and preparing conditioned medium from these human cells. This removes the source of heterologous protein contamination while maintaining the necessary culture support functions, thereby resolving the safety issue without compromising stem cell culture capability.
2Reliability
If expensive special gel is used for stem cell culture, then stem cell proliferation can be maintained, but economic viability for mass production is compromised
Solution Approach 1:
The patent replaces expensive, specialized gels with a cost-effective conditioned medium prepared from placenta-derived fibroblast-like cells. These feeder cells can be easily cultured and harvested, providing a economical alternative that maintains stem cell proliferation capabilities while significantly reducing production costs for mass application.
3Ease of manufacture
If placenta-derived cell-conditioned medium is used for dedifferentiation, then animal-free and feeder-free culture is achieved, but dedifferentiation efficiency needs to be enhanced
Solution Approach 1:
The patent optimizes the conditioned medium formulation by adjusting the ratio of placenta-derived fibroblast-like cells to stem cells, controlling culture conditions (temperature, pH, gas composition), and modifying medium composition (serum-free formulations, growth factors). These parameter changes enhance dedifferentiation efficiency while maintaining the animal-free and feeder-free advantages.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach increases the efficiency of dedifferentiation into induced pluripotent stem cells, allowing for stable establishment of personalized stem cells using only human-derived products, thereby enhancing safety and economic viability.
Implementation Method 1
proliferation and differentiation of pluripotent stem cells can be performed by the mechanism of CXCR2 which is a chemokine receptor
Data Source
Figure 5b
Figure 5c
Figure 6a
AI summary
The present disclosure relates to a placenta-derived cell-conditioned medium for inducing dedifferentiation into induced pluripotent stem cells from somatic cells and a method for inducing dedifferentiation using the same. When the placenta-derived cell-conditioned medium for inducing dedifferentiation according to the present disclosure is employed, personalized dedifferentiation stem cells can be stably established using a medium composed of human-derived products only. Provision of a human placenta-derived environment similarly represents an in vivo environment and allows the production of a cell therapy product without problems for clinical application.